Pacira | Umsatzkosten



Cost Of Sales Veränderung Datum
Astellas Pharma JPY 94.83B 17.97B 2025-06
Bristol-Myers Squibb USD 3.37B 339M 2025-06
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
J&J USD 7.6B 304M 2025-06
Ligand Pharmaceuticals USD 11.16M 6.32M 2025-06
Novo Nordisk 12.85B 44M 2025-06
Pacira USD 55.19M 20.88M 2025-06
Perrigo USD 693.4M 41.8M 2025-06
Pfizer USD 4.99B 2.4B 2025-06
Supernus Pharmaceuticals USD 37.65M 21.88M 2025-06
Teva Pharmaceutical Industries USD 2.07B 97M 2025-06
Xeris Pharmaceuticals USD 11.9M 2.42M 2025-06
Zoetis USD 682M 60M 2025-06


Pacira Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2025.